Participants:18–64 years · 65+ years
Substances:N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Autoimmune haemolytic anaemia+1

Not recruiting

Registered drugNo placebo

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drug

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Comparing inavolisib plus fulvestrant versus alpelisib plus fulvestrant in patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ammonium Chloride

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

Polycythaemia vera

Not recruiting

Investigational

Study of SLN124 for Patients with Polycythemia Vera

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Tmprss6 Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 35

439 trials match your criteria

Metastatic malignant melanoma

Study on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments

T-cell lymphoma

Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Plasma cell myeloma

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Mantle cell lymphoma refractory

Study of BGB-11417 for Patients with Relapsed or Refractory Mantle Cell Lymphoma

Renal cell carcinoma

Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

Autoimmune haemolytic anaemia+1

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Triple negative breast cancer

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Breast cancer+2

Comparing inavolisib plus fulvestrant versus alpelisib plus fulvestrant in patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Small cell lung cancer recurrent

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Polycythaemia vera

Study of SLN124 for Patients with Polycythemia Vera

Non-small cell lung cancer

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.